Post by Med Tech Gurus

The biggest commercialization failures in life sciences rarely happen because the science falls short. More often, they happen because development and commercial teams stop talking to each other. On MedTech Gurus, Joseph Luminiello, CEO and Co-Founder of RCG Intel, explains why cross-functional alignment is one of the strongest predictors of a successful product launch. By the time commercial teams receive a product, many of the decisions that shape its market potential have already been made. Product profiles, clinical endpoints, and labeling are often established years earlier, leaving marketing and sales teams to build a launch strategy around decisions they had little opportunity to influence. Joseph highlights several leadership lessons from his career: • Bring commercial teams into the conversation early, not months before launch • Build accountability across development, marketing, and sales from day one • Create communication structures that connect strategy with field execution • Use AI to accelerate analysis, but rely on experienced people to provide context and judgment • Plan for the market you’ll launch into, not the market that exists today One insight stands out. Organizations often invest heavily in technology while overlooking the communication systems that connect their teams. No amount of data or AI can compensate for departments operating in silos or leaders working toward different objectives. For MedTech and life sciences leaders, the message is clear: successful commercialization is not only about developing a great product. It is about building an organization where clinical, commercial, and strategic teams move in the same direction from the very beginning. Watch the full conversation to hear Joseph’s framework for aligning teams, strengthening commercial strategy, and turning competitive intelligence into better business decisions. #MedTechGurus #CommercialStrategy #LifeSciencesLeadership #CompetitiveIntelligence #SalesAndMarketing

Video Content